Regression of radiation-induced macular edema after systemic bevacizumab

Joel M. Solano, Sophie J. Bakri, Jose S. Pulido

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Case report: A 59-year-old patient with a coexisting primary choroidal melanoma and colorectal cancer was treated with external beam radiation (EBR) of his choroidal melanoma and systemic chemotherapy with leukovorin/5 fluorouracil (FU) for treatment of his metastatic colorectal cancer. Eight months following EBR, he showed evidence of radiation retinopathy with macular edema. Optical coherence tomography (OCT) showed macular edema and subretinal fluid. Subsequently, systemic bevacizumab (5 mg/kg) was added to his leukovorin/5FU chemotherapy. After the addition of bevacizumab, OCT showed complete resolution of the macular edema and subretinal fluid. Comments: Bevacizumab may have a role in the treatment of radiation retinopathy, but further investigation is needed before any definitive conclusions can be made.

Original languageEnglish (US)
Pages (from-to)748-749
Number of pages2
JournalCanadian Journal of Ophthalmology
Issue number5
StatePublished - Oct 2007


  • Avastin
  • Bevacizumab
  • Macular edema
  • Radiation
  • Retina
  • Retinopathy

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Regression of radiation-induced macular edema after systemic bevacizumab'. Together they form a unique fingerprint.

Cite this